Can a single dose of Modified Vaccinia Ankara-Bavarian Nordic vaccine protect against mpox?

por Ogoina, Dimie, Strub-Wourgaft, Nathalie
Publicado 2023

Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program

por Valverde Mordt, Olaf, Tarral, Antoine, Strub-Wourgaft, Nathalie
Publicado 2022

The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?

por Guerin, Philippe J, Singh-Phulgenda, Sauman, Strub-Wourgaft, Nathalie
Publicado 2020

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole

por Neau, Philippe, Hänel, Heinz, Lameyre, Valérie, Strub-Wourgaft, Nathalie, Kuykens, Luc
Publicado 2020

Guidelines should not pool evidence from uncomplicated and severe COVID-19

por White, Nicholas J, Strub-Wourgaft, Nathalie, Faiz, Abul, Guerin, Philippe J
Publicado 2021

WHO COVID-19 therapeutic guidelines – Authors' reply

por White, Nicholas J, Strub-Wourgaft, Nathalie, Faiz, Abul, Guerin, Philippe J
Publicado 2021

Registering New Drugs for Low-Income Countries: The African Challenge

por Moran, Mary, Strub-Wourgaft, Nathalie, Guzman, Javier, Boulet, Pascale, Wu, Lindsey, Pecoul, Bernard
Publicado 2011

Report of the Post Kala-Azar Dermal Leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27–29 June 2012

por Desjeux, Philippe, Ghosh, Raj Shankar, Dhalaria, Pritu, Strub-Wourgaft, Nathalie, Zijlstra, Ed E
Publicado 2013

Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants

por Hentzien, Maxime, Owen, Andrew, Strub-Wourgaft, Nathalie, Pérez-Casas, Carmen, Trøseid, Marius, Calmy, Alexandra
Publicado 2022

Inclusion of women susceptible to and becoming pregnant in preregistration clinical trials in low- and middle-income countries: A proposal for neglected tropical diseases

por Couderc-Pétry, Monique, Eléfant, Elisabeth, Wasunna, Monique, Mwinga, Alwyn, Kshirsagar, Nilima A., Strub-Wourgaft, Nathalie
Publicado 2020

A new patient registry for Chagas disease

por Hotez, Peter, Bottazzi, Maria Elena, Strub-Wourgaft, Nathalie, Sosa-Estani, Sergio, Torrico, Faustino, Pajín, Leire, Abril, Marcelo, Sancho, Javier
Publicado 2020

Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis

por Guérin, Philippe J., McLean, Alistair R. D., Rashan, Sumayyah, Lawal, AbdulAzeez, Watson, James A., Strub-Wourgaft, Nathalie, White, Nicholas J.
Publicado 2022

Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual p...

por Bush, Jacob T., Wasunna, Monique, Alves, Fabiana, Alvar, Jorge, Olliaro, Piero L., Otieno, Michael, Sibley, Carol Hopkins, Strub Wourgaft, Nathalie, Guerin, Philippe J.
Publicado 2017

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials

por Thorlund, Kristian, Smith, Davey, Linsell, Christopher, White, Nicholas, Butler, Christopher, Boulware, David, Currier, Judith, Harari, Ofir, Lhomme, Edouard, Strub-Wourgaft, Nathalie, Adam, Stacey, Mills, Edward
Publicado 2023

Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies

por Tarral, Antoine, Blesson, Séverine, Mordt, Olaf Valverde, Torreele, Els, Sassella, Daniela, Bray, Michael A., Hovsepian, Lionel, Evène, Eric, Gualano, Virginie, Felices, Mathieu, Strub-Wourgaft, Nathalie
Publicado 2014

Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study

por Tarral, Antoine, Hovsepian, Lionel, Duvauchelle, Thierry, Donazzolo, Yves, Latreille, Mathilde, Felices, Mathieu, Gualano, Virginie, Delhomme, Sophie, Valverde Mordt, Olaf, Blesson, Severine, Voiriot, Pascal, Strub-Wourgaft, Nathalie
Publicado 2023

The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual partici...

por Maguire, Brittany J., Dahal, Prabin, Rashan, Sumayyah, Ngu, Roland, Boon, Anca, Forsyth, Colin, Strub-Wourgaft, Nathalie, Chatelain, Eric, Barreira, Fabiana, Sosa-Estani, Sergio, Guérin, Philippe J.
Publicado 2021

Towards a universal understanding of post COVID-19 condition

por Diaz, Janet V, Herridge, Margaret, Bertagnolio, Silvia, Davis, Hannah E, Dua, Tarun, Kaushic, Charu, Marshall, John C, del Rosario Pérez, Maria, Strub-Wourgaft, Nathalie, Soriano, Joan B
Publicado 2021

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh

por Rahman, Ridwanur, Goyal, Vishal, Haque, Rashidul, Jamil, Kazi, Faiz, Abul, Samad, Rasheda, Ellis, Sally, Balasegaram, Manica, den Boer, Margriet, Rijal, Suman, Strub-Wourgaft, Nathalie, Alves, Fabiana, Alvar, Jorge, Sharma, Bhawna
Publicado 2017

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

por Torrico, Faustino, Gascón, Joaquim, Ortiz, Lourdes, Pinto, Jimy, Rojas, Gimena, Palacios, Alejandro, Barreira, Fabiana, Blum, Bethania, Schijman, Alejandro Gabriel, Vaillant, Michel, Strub-Wourgaft, Nathalie, Pinazo, Maria-Jesus, Bilbe, Graeme, Ribeiro, Isabela
Publicado 2022